Industry

DUBLIN–(BUSINESS WIRE)–The “Anemia And Other Blood Disorder Drugs Global Market Report 2022, Type, Distribution Channel, Route of Administration, Anemia Type” report has been added to ResearchAndMarkets.com’s offering. The global anemia and other blood disorder drugs market is expected to grow from $10.29 billion in 2021 to $11.10 billion in 2022 at a compound annual growth … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Healthcare Nanotechnology Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global healthcare nanotechnology market is expected to grow from $242.49 billion in 2021 to $276.41 billion in 2022 at a compound annual growth rate (CAGR) of 13.99%. The market is expected to grow to $478.94 billion in 2026 at … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $13,359.1 million … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The publisher’s Medical Devices sector report, Neurosurgical Products Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it is advising The CM Group, a portfolio company of NaviMed Capital (NaviMed), on its pending sale to OPEN Health, a portfolio company of Astorg. The CM Group is a leading medical communications platform offering a set of integrated solutions to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “North America Antibody Drug Conjugates Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. Market Drivers The rising prevalence of cancer is the primary driver of the antibody drug conjugates market in North America. Because cancer claims millions of lives each year and is on the rise, the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Cathepsin K Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Cathepsin K Inhibitor – Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Cathepsin K Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Isocitrate Dehydrogenase (IDH) inhibitors- Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. This “Isocitrate Dehydrogenase (IDH) inhibitors – Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Isocitrate Dehydrogenase (IDH) inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Corporate Wellness Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Corporate Wellness Market is projected to reach USD 81,715.37 million by 2027 from USD 42,138.66 million in 2021, at a CAGR 11.67% during the forecast period. Market Statistics: The Americas Corporate Wellness Market size … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Progesterone Receptor (PR) Antagonist – Pipeline Insight, 2022” offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Progesterone Receptor (PR) Antagonist development. The report provides detailed coverage of the pipeline landscape for … [Read more…]